James S. Hewlett

Prognostic factors in multiple myeloma

Raymond Alexanian, Stanley P. Balcerzak, John D. Bonnet et al. · Cancer · 1975 · 233 citations

Hematological Malignancy, Bone Marrow Failure, Medicine +14

Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878).

Emil Frei, John N. Bickers, James S. Hewlett et al. · PubMed · 1969 · 215 citations

Bone Marrow Function, Immunology, Pharmacotherapy +18

Combination chemotherapy for multiple myeloma

Raymond Alexanian, John D. Bonnet, Edmund A. Gehan et al. · Cancer · 1972 · 210 citations · Full text

Hematological Malignancy, Immunotherapy, Medicine +14

Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphoma

James K. Luce, Jess F. Gamble, Henry E. Wilson et al. · Cancer · 1971 · 196 citations · Full text

Lymphoid Neoplasia, Medicine, Malignant Blood Disorder +11

Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study.

Muhyi Al‐Sarraf, William S. Fletcher, N Oishi et al. · PubMed · 1982 · 134 citations

Surgical Oncology, Pharmacotherapy, Malignant Melanoma +17